

Health Care: Drugs
Acorda Therapeutics Inc. (ACOR: NASDAQ)
$32.67 0.44 | 1.37%
05/24/13 - 04:00 PM ET
Insider Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Net Insider Transaction |
62,801 |
62,801 |
26,900 |
26,900 |
26,900 |
0 |
0 |
| Shares Bought |
62,801 |
95,568 |
72,248 |
72,248 |
39,481 |
0 |
0 |
| Shares Sold |
0 |
32,767 |
45,348 |
45,348 |
12,581 |
0 |
0 |
Institutional Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Total Shares Held |
37.57M |
37.49M |
37.67M |
38.65M |
41.87M |
38.02M |
36.62M |
| Shares Bought |
4.32M |
5.70M |
5.84M |
6.78M |
10.39M |
5.63M |
5.61M |
| Shares Sold |
5.81M |
5.15M |
5.21M |
4.81M |
3.34M |
4.35M |
4.17M |
Partner Headlines for ACOR
- Alkermes Earnings Beat Estimates, But Outlook Unclear - Investor's Business Daily 05.23.13 | 06:05 pm
- Acorda Therapeutics, Inc. (ACOR): Today's Most Compelling Stock Buy - NASDAQ 05.13.13 | 04:05 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Acorda Beats on All Fronts - Analyst Blog - Zacks 11.02.12 | 09:11 am
- After Hours Most Active for Oct 4, 2012 : SUN, PETM, AMAT, QQQ, CAB, ACOR, NVDA, BAC, ORCL, A, NOK, HPQ - NASDAQ 10.04.12 | 08:10 pm
- Back to Neutral on Alkermes - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Acorda Reports Data on Ampyra study - Analyst Blog - Zacks 08.14.12 | 05:08 pm
- Pre-Market Earnings Report for July 31, 2012 : BP, ADM, AET, AMG, WTR, BRKR, AVX, AUXL, ACOR, ALLT, CPLP, ABFS - NASDAQ 07.30.12 | 08:07 pm
- Revenues Climb at Acorda - Analyst Blog - Zacks 05.04.12 | 06:05 pm